Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for BKTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Research and Development Expense (TTM) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 0.0082M
March 31, 2026 0.0042M
December 31, 2025 0.0018M
September 30, 2025 0.0024M
June 30, 2025
March 31, 2024
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
October 31, 2014
July 31, 2014
April 30, 2014
January 31, 2014
Date Value
October 31, 2013 0.00
July 31, 2013 0.00
April 30, 2013 0.00
January 31, 2013 0.00
October 31, 2012 0.00
July 31, 2012 0.00
April 30, 2012
January 31, 2012
October 31, 2011
July 31, 2011
April 30, 2011 0.00
January 31, 2011 0.00
October 31, 2010
July 31, 2010
April 30, 2010
January 31, 2010
October 31, 2009
July 31, 2009
April 30, 2009
January 31, 2009
October 31, 2008
July 31, 2008
April 30, 2008
January 31, 2008
October 31, 2007

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Cardiac Biotech Solutions, Inc. --
Precision Optics Corp., Inc. 1.057M
Petros Pharmaceuticals, Inc. --
RxSight, Inc. 36.67M
Vyome Holdings, Inc. 1.591M